Yuk M Law

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi request reprint Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens
    Yuk M Law
    Department of Pediatrics, Doernbecher Children s Hospital, Oregon Health and Science University, Portland, Oregon 97239, USA
    J Heart Lung Transplant 25:276-82. 2006
  2. ncbi request reprint Clinically significant thrombosis in pediatric heart transplant recipients during their waiting period
    Yuk M Law
    Department of Pediatrics, Seattle Children s Hospital, University of Washington, 4800 Sand Point Way NE, G 0039, Seattle, WA 98105, USA
    Pediatr Cardiol 34:334-40. 2013
  3. pmc Cardiopulmonary manifestations of portovenous shunts from congenital absence of the portal vein: pulmonary hypertension and pulmonary vascular dilatation
    Y M Law
    Department of Pediatrics, Seattle Children s Hospital, Seattle, Washington 98105, USA
    Pediatr Transplant 15:E162-8. 2011
  4. ncbi request reprint Pathophysiology and diagnosis of allograft rejection in pediatric heart transplantation
    Yuk M Law
    Pediatric Cardiology, Children s Hospital and Regional Medical Center, University of Washington, Seattle, Washington 98105, USA
    Curr Opin Cardiol 22:66-71. 2007
  5. doi request reprint Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study
    Yuk M Law
    Pediatric Cardiology, Department of Pediatrics, Children s Hospital and Regional Medical Center, University of Washington, Seattle, Washington 98105, USA
    J Am Coll Cardiol 54:1467-75. 2009
  6. doi request reprint Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?
    David M Peng
    University of Washington Seattle Children s Hospital, Seattle, WA, USA
    Pediatr Transplant 17:429-35. 2013
  7. ncbi request reprint Human leukocyte antigen sensitization in pediatric patients exposed to mechanical circulatory support
    Borah J Hong
    From the Division of Pediatric Cardiology, Texas Children s Hospital, Baylor College of Medicine, Houston, Texas Puget Sound Blood Center, Seattle, Washington University of Washington School of Medicine, Seattle, Washington Division of Pediatric Cardiothoracic Surgery, Seattle Children s Hospital, University of Washington, Seattle, Washington and Division of Pediatric Cardiology, Seattle Children s Hospital, University of Washington, Seattle, Washington
    ASAIO J 60:317-21. 2014
  8. pmc Risk factors for late renal dysfunction after pediatric heart transplantation: a multi-institutional study
    Brian Feingold
    Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA
    Pediatr Transplant 15:699-705. 2011
  9. doi request reprint Mitochondrial electron transport chain deficiency, cardiomyopathy, and long-term cardiac transplant outcome
    Alana S Golden
    Division of Pediatric Neurology, Seattle Children s Hospital and University of Washington, Seattle, WA 98105, USA
    Pediatr Transplant 16:265-8. 2012
  10. ncbi request reprint Nesiritide use in pediatric patients with congestive heart failure
    Brian Feingold
    Division of Cardiology, Department of Pediatrics, Children s Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
    J Heart Lung Transplant 23:1455-9. 2004

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens
    Yuk M Law
    Department of Pediatrics, Doernbecher Children s Hospital, Oregon Health and Science University, Portland, Oregon 97239, USA
    J Heart Lung Transplant 25:276-82. 2006
    ..Controversy exists over the pattern of lipidemic effects from calcineurin inhibitors and prednisone. We report an extensive longitudinal study of lipid profiles in pediatric thoracic transplant recipients...
  2. ncbi request reprint Clinically significant thrombosis in pediatric heart transplant recipients during their waiting period
    Yuk M Law
    Department of Pediatrics, Seattle Children s Hospital, University of Washington, 4800 Sand Point Way NE, G 0039, Seattle, WA 98105, USA
    Pediatr Cardiol 34:334-40. 2013
    ..Until randomized clinical trial data are available, it may be reasonable to consider anticoagulation for children admitted with decompensated heart failure and listed as UNOS status 1...
  3. pmc Cardiopulmonary manifestations of portovenous shunts from congenital absence of the portal vein: pulmonary hypertension and pulmonary vascular dilatation
    Y M Law
    Department of Pediatrics, Seattle Children s Hospital, Seattle, Washington 98105, USA
    Pediatr Transplant 15:E162-8. 2011
    ..These cases illustrate associations that must be entertained in the setting of heterotaxy syndrome, cyanosis, or pulmonary hypertension and how strategic medical combined with surgical management can provide a good outcome...
  4. ncbi request reprint Pathophysiology and diagnosis of allograft rejection in pediatric heart transplantation
    Yuk M Law
    Pediatric Cardiology, Children s Hospital and Regional Medical Center, University of Washington, Seattle, Washington 98105, USA
    Curr Opin Cardiol 22:66-71. 2007
    ..Attempts at improving diagnostic monitoring of allograft rejection continue at a steady pace. The main issue remains whether these methods will replace the standard method of tissue histology from endomyocardial biopsy...
  5. doi request reprint Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study
    Yuk M Law
    Pediatric Cardiology, Department of Pediatrics, Children s Hospital and Regional Medical Center, University of Washington, Seattle, Washington 98105, USA
    J Am Coll Cardiol 54:1467-75. 2009
    ..The purpose of this study was to assess the ability of plasma B-type natriuretic peptide (BNP) to diagnose significant cardiovascular disease (CVD) in the pediatric population...
  6. doi request reprint Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?
    David M Peng
    University of Washington Seattle Children s Hospital, Seattle, WA, USA
    Pediatr Transplant 17:429-35. 2013
    ..In post-transplant care, quantitative DSA should be an essential component in the surveillance for AMR. ..
  7. ncbi request reprint Human leukocyte antigen sensitization in pediatric patients exposed to mechanical circulatory support
    Borah J Hong
    From the Division of Pediatric Cardiology, Texas Children s Hospital, Baylor College of Medicine, Houston, Texas Puget Sound Blood Center, Seattle, Washington University of Washington School of Medicine, Seattle, Washington Division of Pediatric Cardiothoracic Surgery, Seattle Children s Hospital, University of Washington, Seattle, Washington and Division of Pediatric Cardiology, Seattle Children s Hospital, University of Washington, Seattle, Washington
    ASAIO J 60:317-21. 2014
    ..Diagnosis, MCS duration, and volume of transfused blood products do not appear to be associated with HLA sensitization, but there is a suggestion of an association with older age at MCS and history of a homograft. ..
  8. pmc Risk factors for late renal dysfunction after pediatric heart transplantation: a multi-institutional study
    Brian Feingold
    Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA
    Pediatr Transplant 15:699-705. 2011
    ..Decreased eGFR at one yr post-HTx, but not at HTx, predicts onset of late renal dysfunction. Future research on strategies to minimize late renal dysfunction after pediatric HTx may be of greatest benefit if focused on these subgroups...
  9. doi request reprint Mitochondrial electron transport chain deficiency, cardiomyopathy, and long-term cardiac transplant outcome
    Alana S Golden
    Division of Pediatric Neurology, Seattle Children s Hospital and University of Washington, Seattle, WA 98105, USA
    Pediatr Transplant 16:265-8. 2012
    ..Our results suggest that with proper patient selection in this population, cardiac transplantation is feasible and can have good outcomes...
  10. ncbi request reprint Nesiritide use in pediatric patients with congestive heart failure
    Brian Feingold
    Division of Cardiology, Department of Pediatrics, Children s Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
    J Heart Lung Transplant 23:1455-9. 2004
    ....
  11. ncbi request reprint Long-term comparison of tacrolimus- and cyclosporine-induced nephrotoxicity in pediatric heart-transplant recipients
    Robert F English
    Division of Pediatric Cardiology, Children s Hospital of Pittsburgh, USA
    Am J Transplant 2:769-73. 2002
    ..We conclude that the nephrotoxicities of tacrolimus and cyclosporine are comparable over the medium- to long-term in pediatric heart-transplant recipients...